4.6 Editorial Material

Using SARS-CoV-2 Antibody Testing in COVID-19 Research

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Physical Activity, Sedentary Behavior, and Risk of Coronavirus Disease 2019

Wenjie Ma et al.

Summary: According to data from the Nurses' Health Study II and Health Professionals Follow-Up Study, there is a correlation between prepandemic physical activity and lower risk and severity of SARS-CoV-2 infection and COVID-19. Longer periods of sedentary behavior are also associated with lower risk of infection.

AMERICAN JOURNAL OF MEDICINE (2023)

Letter Medicine, General & Internal

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Sebastian Havervall et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Immunology

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination

Alok R. Amraotkar et al.

Summary: The presence of chronic health conditions, especially chronic kidney disease and autoimmune disease, increases the likelihood of seronegative status among individuals who are fully vaccinated to SARS-CoV-2. The absence of any chronic health conditions is protective and increases the likelihood of a positive serological response. The risk of seronegative status increases with an increase in the number of comorbidities and the use of CHC-related medications.

VACCINES (2022)

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

News Item Medicine, General & Internal

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity

Jennifer Abbasi

Summary: Experts recommend against using antibody testing to assess protection from SARS-CoV-2 post-vaccination or infection.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Multidisciplinary Sciences

Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky

Krystal T. Hamorsky et al.

Summary: Serological assays are crucial for managing the COVID-19 pandemic, with ELISA methods showing accuracy in measuring antibody responses. The developed ELISA method demonstrated positive correlation with neutralization assays, indicating broad immune responses among individuals.

SCIENTIFIC REPORTS (2021)

Review Immunology

SARS-CoV-2 Vaccines: Status Report

Fatima Amanat et al.

IMMUNITY (2020)

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Article Medicine, Research & Experimental

Kinetics of viral load and antibody response in relation to COVID-19 severity

Yanqun Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)